In summary, considering the dysfunction of P450 enzymes, we made tailored COH strategies and modified the estradiol supplementation in PORD female patients. This evidence concerns the gene CYP2B6 and congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency.